Pharmacogenetics role in the safety of acenocoumarol therapy
E Jimenez-Varo, M Canadas-Garre… - Thrombosis and …, 2014 - thieme-connect.com
Vitamin K antagonists (VKAs) remain as the most prescribed drug for treatment and
prevention of thrombotic disorders in many countries, despite the recent approval of the new …
prevention of thrombotic disorders in many countries, despite the recent approval of the new …
[引用][C] Pharmacogenetics role in the safety of acenocoumarol therapy
E JIMENEZ-VARO… - Thrombosis and …, 2014 - pascal-francis.inist.fr
Pharmacogenetics role in the safety of acenocoumarol therapy CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pharmacogenetics role in the safety of acenocoumarol therapy
E Jiménez-Varo, M Cañadas-Garre… - Thrombosis and …, 2014 - hero.epa.gov
Vitamin K antagonists (VKAs) remain as the most prescribed drug for treatment and
prevention of thrombotic disorders in many countries, despite the recent approval of the new …
prevention of thrombotic disorders in many countries, despite the recent approval of the new …
[PDF][PDF] Pharmacogenetics role in the safety of acenocoumarol therapy
E Jiménez-Varo, M Cañadas-Garre… - Thrombosis and …, 2014 - researchgate.net
Vitamin K antagonists (VKAs) remain as the most prescribed drug for treatment and
prevention of thrombotic disorders in many countries, despite the recent approval of the new …
prevention of thrombotic disorders in many countries, despite the recent approval of the new …
Pharmacogenetics role in the safety of acenocoumarol therapy
E Jiménez-Varo, M Cañadas-Garre… - Thrombosis and …, 2014 - pubmed.ncbi.nlm.nih.gov
Vitamin K antagonists (VKAs) remain as the most prescribed drug for treatment and
prevention of thrombotic disorders in many countries, despite the recent approval of the new …
prevention of thrombotic disorders in many countries, despite the recent approval of the new …
Pharmacogenetics role in the safety of acenocoumarol therapy
E Jiménez-Varo, M Cañadas-Garre… - Thrombosis and …, 2014 - thieme-connect.com
Vitamin K antagonists (VKAs) remain as the most prescribed drug for treatment and
prevention of thrombotic disorders in many countries, despite the recent approval of the new …
prevention of thrombotic disorders in many countries, despite the recent approval of the new …
Pharmacogenetics role in the safety of acenocoumarol therapy.
E Jiménez-Varo, M Cañadas-Garre… - Thrombosis and …, 2014 - europepmc.org
Vitamin K antagonists (VKAs) remain as the most prescribed drug for treatment and
prevention of thrombotic disorders in many countries, despite the recent approval of the new …
prevention of thrombotic disorders in many countries, despite the recent approval of the new …
